Volicure Trio 1 mg/500 mg/0.2 mg Tablet
By Volicure Trio
Rx
10 Tablet in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - HBC Lifesciences Pvt Ltd
Office No: B,412-419, Atria-the business hub, Kh Road, Sargasan Cross Roads, S.G.Highway, Gandhinagar-382421., Gujarat, India.

Expires on or after
August, 2025

liver
Volicure Trio 1 mg/500 mg/0.2 mg Tablet needs to be used carefully in individuals with liver problems. It might be necessary to adjust the dose of Volicure Trio 1 mg/500 mg/0.2 mg Tablet, so it is essential to seek advice from your doctor. Usually, Volicure Trio 1 mg/500 mg/0.2 mg Tablet is initially prescribed in smaller amounts for individuals with mild to moderate liver disease. However, it is advisable to avoid using this medication in cases of severe liver disease.

kidney
Volicure Trio 1 mg/500 mg/0.2 mg Tablet may not be safe for patients with kidney disease and is not recommended, especially for those with severe kidney issues. Please consult your doctor before using.

alcohol
It is not safe to drink alcohol while taking Volicure Trio 1 mg/500 mg/0.2 mg Tablet.

driving
Caution - Driving Your ability to drive may be impacted if your blood sugar levels are too low or too high. Avoid driving if you experience these symptoms.

pregnancy
Volicure Trio 1 mg/500 mg/0.2 mg Tablet may be unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Please consult your doctor before use.

breastfeeding
Using Volicure Trio 1 mg/500 mg/0.2 mg Tablet while breastfeeding may not be safe. Limited data indicates that the medication could enter breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹119
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024